Cargando…

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages

The landscape of SARS-CoV-2 variants dramatically diversified with the simultaneous appearance of multiple subvariants originating from BA.2, BA.4, and BA.5 Omicron sub-lineages. They harbor a specific set of mutations in the spike that can make them more evasive to therapeutic monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Touret, Franck, Giraud, Emilie, Bourret, Jérôme, Donati, Flora, Tran-Rajau, Jaouen, Chiaravalli, Jeanne, Lemoine, Frédéric, Agou, Fabrice, Simon-Lorière, Etienne, van der Werf, Sylvie, de Lamballerie, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015083/ https://www.ncbi.nlm.nih.gov/pubmed/36968074 http://dx.doi.org/10.1016/j.isci.2023.106413

Ejemplares similares

Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model
por: Hérate, Cécile, et al.
Publicado: (2023)

In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
por: Touret, Franck, et al.
Publicado: (2022)

Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2023)

In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
por: Touret, Franck, et al.
Publicado: (2022)

Of chloroquine and COVID-19
por: Touret, Franck, et al.
Publicado: (2020)

Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
por: Planchais, Cyril, et al.
Publicado: (2022)

Omicron, the great escape artist
por: Flemming, Alexandra
Publicado: (2022)

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
por: Arora, Prerna, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance
por: Montagutelli, Xavier, et al.
Publicado: (2022)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
por: Lewnard, Joseph A., et al.
Publicado: (2023)

Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium
por: Touret, Franck, et al.
Publicado: (2021)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura A., et al.
Publicado: (2022)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
por: Pastorino, Boris, et al.
Publicado: (2020)

Prolonged Infectivity of SARS-CoV-2 in Fomites
por: Pastorino, Boris, et al.
Publicado: (2020)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

High-Content RNAi Phenotypic Screening Unveils the Involvement of Human Ubiquitin-Related Enzymes in Late Cytokinesis
por: Boullé, Mikaël, et al.
Publicado: (2022)

Antibody escape and global spread of SARS-CoV-2 lineage A.27
por: Kaleta, Tamara, et al.
Publicado: (2022)

Omicron: the highly mutational COVID-19 variant with immune escape
por: Khajotia, Rumi
Publicado: (2022)

SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations
por: García-López, Rodrigo, et al.
Publicado: (2023)

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
por: Touret, Franck, et al.
Publicado: (2018)

Complete Coding Sequences of Two Dengue Virus Type 2 Strains Isolated from an Outbreak in Burkina Faso in 2016
por: Baronti, Cécile, et al.
Publicado: (2017)

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
por: Case, James Brett, et al.
Publicado: (2022)

Omicron variant evolution on vaccines and monoclonal antibodies
por: Sabbatucci, Michela, et al.
Publicado: (2023)

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
por: Zhao, Zhennan, et al.
Publicado: (2022)

Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
por: Boschi, Céline, et al.
Publicado: (2022)

Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples
por: Pastorino, Boris, et al.
Publicado: (2020)

Spherical neutralizing aptamer suppresses SARS-CoV-2 Omicron escape
por: Sun, Miao, et al.
Publicado: (2022)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
por: Cao, Yunlong, et al.
Publicado: (2021)

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
por: Cele, Sandile, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
por: Yao, Lin, et al.
Publicado: (2022)

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
por: Arora, Prerna, et al.
Publicado: (2023)

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
por: Gupta, Ravindra
Publicado: (2022)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eikpir7alkm4jo0pan7s8sflkb